食品伙伴網(wǎng)訊    據(jù)歐盟食品安全局（EFSA）消息，10月22日歐盟食品安全局發(fā)布了環(huán)唑醇的農(nóng)藥風險評估確認數(shù)據(jù)同成員國、申請人的咨詢結(jié)果。2013年5月先正達公司向愛爾蘭提交申請，愛爾蘭對申請文件進行了風險評估。

    歐盟食品安全局認為，在現(xiàn)有評估數(shù)據(jù)的基礎(chǔ)上，用于監(jiān)控土壤、體液與組織中環(huán)唑醇的方法是可以接受的。

    部分原文報道如下：

    Cyproconazole was included in Annex I to Directive 91/414/EEC on 1 June 2011 by Commission Implementing Directive 2011/56/EU, and has been deemed to be approved under Regulation （EC） No 1107/2009, in accordance with Commission Implementing Regulation （EU） No 540/2011, as amended by Commission Implementing Regulation （EU） No 541/2011. It was a specific provision of the approval that the applicant was required to submit to the European Commission further studies on analytical methods for the monitoring of cyproconazole in soil, body fluids and tissues and on the long-term risk to herbivorous mammals by 31 May 2013.

    The RMS carried out a transparent assessment of the information provided. Based on the evaluation of the confirmatory data submitted, the analytical methods for the monitoring of cyproconazole in soil, body fluids and tissues are considered acceptable by EFSA. A safe use regarding long-term risk to herbivorous mammals has been demonstrated at growth stage 40-69.

    原文鏈接：<http://www.efsa.europa.eu/en/supporting/doc/677e.pdf>